NEW YORK, Jan. 21 - Hyseq's bid to buy Variagenics is still a go after the attention of another suitor was rebuffed, Variagenics said today.
CombiMatrix, owned by Acacia Research Corporation, made an unsolicited merger bid for Variagenics, the company said. The proposal included a stock-for-stock merger.
Variagenics board of directors voted down the proposal and reaffirmed their intention of merging with Hyseq, according to the company.
Click here for more information.